The evaluation of genomic applications in practice and prevention (EGAPP) initiative: Methods of the EGAPP working group

  • Teutsch S
  • Bradley L
  • Palomaki G
 et al. 
  • 154

    Readers

    Mendeley users who have this article in their library.
  • 377

    Citations

    Citations of this article.

Abstract

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative, established by the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, supports the development and implementation of a rigorous, evidence-based process for evaluating genetic tests and other genomic applications for clinical and public health practice in the United States. An independent, non-federal EGAPP Working Group (EWG), a multidisciplinary expert panel selects topics, oversees the systematic review of evidence, and makes recommendations based on that evidence. This article describes the EGAPP processes and details the specific methods and approaches used by the EWG.

Author-supplied keywords

  • Evidence-based medicine
  • Review
  • Systematic

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Steven M. Teutsch

  • Linda A. Bradley

  • Glenn E. Palomaki

  • James E. Haddow

  • Margaret Piper

  • Ned Calonge

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free